StockNews.AI
HAE
StockNews.AI
103 days

Haemonetics 4th Quarter and Fiscal Year 2025 Earnings Release Available on Investor Relations Website

1. Haemonetics released Q4 and FY 2025 financial results online. 2. Conference call scheduled for May 8, 2025, to discuss results. 3. Earnings release includes fiscal 2026 revenue growth guidance. 4. Haemonetics focuses on improving healthcare quality and efficiency. 5. Investor resources available on Haemonetics' website.

6m saved
Insight
Article

FAQ

Why Bullish?

Strong earnings and growth guidance can lead to increased investor confidence. Historical trends show post-earnings announcements can positively impact stock price when guidance is strong.

How important is it?

Financial results and guidance are critical for forecasting stock performance. The clarity of future revenues directly influences investor sentiment.

Why Short Term?

The upcoming earnings call presents immediate insights that could affect stock price. Quick reactions to financials are typical in this sector.

Related Companies

MEDBAXABC
Financial release accessible online, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter and fiscal year 2025, which ended March 29, 2025, are available on its Investor Relations website.The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 8, 2025. The conference call and webcast can be accessed with the following information: Teleconference link: https://register-conf.media-server.com/register/BI8b22e12b203a4693bead05f6d9f68d5d Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start. A live webcast of the call can be accessed on Haemonetics' investor relations website or via the following link: https://edge.media-server.com/mmc/p/4z9yixt9 In addition, the Company has posted to its Investor Relations website the earnings release and certain supplemental tables that will be referenced during the call and include additional information supporting fiscal 2026 total Company and Hospital reported and organic revenue growth guidance.Direct link to 4Q FY25 Earnings Release:https://haemonetics.gcs-web.com/static-files/89295437-34ea-473c-ae6e-409a07328239Direct link to Hospital Reported and Organic Revenue Growth Guidance Supplemental Tables:https://haemonetics.gcs-web.com/static-files/320de990-2769-4b30-beca-eff1ca68bad1 A replay of the conference call and webcast will be available for one year beginning on May 8, 2025, at 11:00 a.m. ET using the conference call webcast link provided in this press release.ABOUT HAEMONETICSHaemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com. Investor Contacts:                                                      Olga Guyette, Vice President-Investor Relations & Treasury          David Trenk, Manager-Investor Relations (781) 356-9763                                                                            (203) 733-4987 [email protected]                                      [email protected]                                                                                Media Contact:         Josh Gitelson, Sr. Director-Global Communications       (781) 356-9776[email protected] SOURCE Haemonetics Corporation WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News